CEACAM5 and adenocarcinoma: Of the 1736 lung cancer patients from the cancer registry group at our institute, serum CEA information at initial diagnosis (CEAIn) was available for 1183 patients with stage IIIB-IV cancer; of these, adenocarcinoma was diagnosed in 715 patients (Fig. 1).